Abstract
Regeneration of bone is critical to the rehabilitation of congenital malformations and defects resulting from trauma or tumor resection in the craniofacial skeleton, as well as defects resulting from periodontal disease or remodeling following tooth extractions. It is the objective of this text to reflect pioneering and significant preclinical and clinical observations, promises, and challenges, of bone morphogenetic proteins (BMPs) with focus on recombinant human BMP-2 (rhBMP-2) but also recombinant human BMP-7 (rhBMP-7) and recombinant human growth/differentiation factor-5 (rhGDF-5) in craniofacial settings to include alveolar bone augmentation for implant dentistry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Nawas B, Schiegnitz E (2014) Augmentation procedures using bone substitute materials or autogenous bone – a systematic review and meta-analysis. Eur J Oral Implantol 7(Suppl 2):S219–S234
Andersson L (2008) Patient self-evaluation of intra-oral bone grafting treatment to the maxillary frontal region. Dent Traumatol 24:164–169
Barboza EP, Leite Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UME (2000) Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 71:488–496
Barboza E, Caúla AL, Caúla F, Oliveira de Souza R, Neto LG, Sorensen RG, Li XJ, Wikesjö UME (2004) Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 75:702–708
Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721–727
Boyne PJ, James RA (1980) Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg 38:613–616
Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17:11–25
Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG (2005) De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63:1693–1707
Caplanis N, Sigurdsson TJ, Rohrer MD, Wikesjö UME (1997) Effect of allogeneic, freeze-dried, demineralized bone matrix on guided bone regeneration in supraalveolar peri-implant defects in dogs. Int J Oral Maxillofac Implants 12:634–642
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990) Identification of transforming growth factor-ß family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843–9847
Chiapasco M, Zaniboni M (2011) Failures in jaw reconstructive surgery with autogenous onlay bone grafts for pre-implant purposes: incidence, prevention and management of complications. Oral Maxillofac Surg Clin North Am 23:1–15
Cochran DL, Nummikoski PV, Jones AA, Makins SR, Turek TJ, Buser D (1997) Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 12:739–748
Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA (1999) Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 70:139–150
Coomes AM, Mealey BL, Huynh-Ba G, Barboza-Arguello C, Moore WS, Cochran DL (2014) Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone. J Periodontol 85:525–535
de Freitas RM, Susin C, Spin-Neto R, Marcantonio C, Wikesjö UME, Violin Dias Pereira LA, Marcantonio E Jr (2013) Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial. J Clin Periodontol 40:968–975
de Freitas RM, Spin-Neto R, Marcantonio E Jr, Pereira LAVD, Wikesjö UME, Susin C (2015) Alveolar ridge and maxillary sinus augmentation using rhBMP-2: a systematic review. Clin Implant Dent Relat Res 17(Suppl 1):e192–e201
Derks J, Tomasi C (2015) Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol 42(Suppl 16):S158–S171
Esposito M, Grusovin MG, Felice P, Karatzopoulos G, Worthington HV, Coulthard P (2009) The efficacy of horizontal and vertical bone augmentation procedures for dental implants – a Cochrane systematic review. Eur J Oral Implantol 2:167–184
Esposito M, Grusovin MG, Rees J, Karasoulos D, Felice P, Alissa R, Worthington H, Coulthard P (2010) Effectiveness of sinus lift procedures for dental implant rehabilitation: a Cochrane systematic review. Eur J Oral Implantol 3:7–26
Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M (2005) Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 76:605–613
Froum SJ, Wallace S, Cho SC, Khouly I, Rosenberg E, Corby P, Froum S, Bromage T, Schoor R, Norman R, Tarnow DP (2013) Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100 % mineralized cancellous bone allograft in maxillary sinus grafting. Int J Periodontics Restorative Dent 33:721–730
Gruber RM, Ludwig A, Merten HA, Achilles M, Pöhling S, Schliephake H (2008) Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a histological and histomorphometric study in the Göttingen miniature pig. Clin Oral Implants Res 19:522–529
Gruber RM, Ludwig A, Merten HA, Pippig S, Kramer FJ, Schliephake H (2009) Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Göttingen miniature pig comparing autogenous bone and rhGDF-5. Clin Oral Implants Res 20:175–182
Hanisch O, Tatakis DN, Rohrer MD, Wöhrle PS, Wozney JM, Wikesjö UME (1997) Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 12:785–792
Hanisch O, Cortella CA, Boskovic MM, James RA, Slots J, Wikesjö UME (1997) Experimental peri-implant tissue breakdown around hydroxyapatite-coated implants. J Periodontol 68:59–66
Hanisch O, Tatakis DN, Boskovic M,M, Rohrer MD, Wikesjö UME (1997c) Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12:604–610
Heitz-Mayfield LJ, Mombelli A (2014) The therapy of peri-implantitis: a systematic review. Int J Oral Maxillofac Implants 29(Suppl):325–345
Herberg S, Siedler M, Pippig S, Schuetz A, Dony C, Kim C-K, Wikesjö UME (2008) Development of an injectable composite as a carrier for growth factor enhanced periodontal regeneration. J Clin Periodontol 3:976–984
Herberg S, Susin C, Pelaez M, Howie N, Moreno de Freitas R, Lee J, Johnson MH, Elsalanty ME, Hamrick MW, Isales CM, Wikesjö UME, Hill WD (2014) Low-dose bone morphogenetic protein-2 / stromal cell-derived factor-1β co-therapy induces bone in critical-size rat calvarial defects. Tissue Eng Part A 20(9–10):1444–1453
Hötten G, Neidhardt H, Jacobowsky B, Pohl J (1994) Cloning and expression of recombinant human growth/differentiation factor 5. Biochem Biophys Res Commun 204:646–652
Hötten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shrai T, Pan H, Kawai S, Pohl JS, Kudo A (1996) Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13:65–74
Hsu WK, Wang JC (2008) The use of bone morphogenetic protein in spine fusion. Spine J 8:419–425
Hunt DR, Jovanovic SA, Wikesjö UME, Wozney JM, Bernard GW (2001) Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. J Periodontol 72:651–658
Jones AA, Buser D, Schenk R, Wozney JM, Cochran DL (2006) The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 77:1184–1193
Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, Wikesjö UME (2003) Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 14:793–803
Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Wozney JM, Wikesjö UME (2007) Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res 18:224–230
Kao DW, Kubota A, Nevins M, Fiorellini JP (2012) The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation. Int J Periodontics Restorative Dent 32:61–67
Koch FP, Becker J, Terheyden H, Capsius B, Wagner W (2010) A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto ß-tricalcium phosphate for sinus lift augmentation. Clin Oral Implants Res 21:1301–1308
Lacroix P (1945) Recent investigations on the growth of bone. Nature 156:576
Lee J, Wikesjö UME (2014) Growth/differentiation factor-5: pre-clinical and clinical evaluations of periodontal regeneration and alveolar augmentation - Review. J Clin Periodontol 41:797–805
Lee J, Lee EN, Yoon J, Chung S-M, Prasad H, Susin C, Wikesjö UME (2013) Comparative study of Chinese Hamster Ovary cell- versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model. J Periodontol 84:415–422
Lee J, Susin C, Rodriguez NA, de Stefano J, Prasad HS, Buxton AN, Wikesjö UME (2013) Sinus augmentation using rhBMP-2/ACS in a mini-pig model: Relative efficacy of autogenous fresh particulate iliac bone grafts. Clin Oral Implants Res 24:497–504
Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UME (2008) Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2 (rhBMP-2): radiographic observations. Clin Oral Implants Res 19:1027–1033
Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UME (2008) Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): radiographic observations. J Clin Periodontol 35:914–919
Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UME (2013) Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor −5 (rhGDF-5): radiographic observations. Clin Oral Implants Res 24:1185–1191
Levander G (1938) A study of bone regeneration. J Sur Gynecol Obstet 67:705–714
Lu SX, Fiorini T, Lee J, Prasad HS, Buxton AN, Bisch FC, Dixon DR, Susin C, Wikesjö UME (2013) Evaluation of a compression resistant carrier for recombinant human bone morphogenetic protein-2. J Clin Periodontol 40:688–697
McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int Orthop 31:729–734
Miranda DAO, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjö UME (2005) Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 76:210–220
Mombelli A, Müller N, Cionca N (2012) The epidemiology of peri-implantitis. Clin Oral Implants Res 23(Suppl 6):67–76
Nkenke E, Neukam FW (2014) Autogenous bone harvesting and grafting in advanced jaw resorption: morbidity, resorption and implant survival. Eur J Oral Implantol 7(Suppl 2):S203–S217
Orell, S. (1934) Studien über Knochenimplantation und Knochenneubildung, Implantation von ‘Os Purum’ sowie Transplantation von ‘Os Novum.’ Acta Chirurgica Scandinavica 74 Supplement 31.
Özkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H (1990) OP-1 cDNA encodes an osteogenic protein in the TGF-ß family. EMBO J 9:2085–2093
Pelaez M, Susin C, Lee J, Fiorini T, Bisch FC, Dixon DR, McPherson JC III, Buxton AM, Wikesjö UME (2014) Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model. J Clin Periodontol 41:827–836
Persson LG, Berglundh T, Lindhe J, Sennerby L (2001) Re-osseointegration after treatment of peri-implantitis at different implant surfaces. An experimental study in the dog. Clin Oral Implants Res 12:595–603
Pjetursson BE, Tan WC, Zwahlen M, Lang NP (2008) A systematic review of the success of sinus floor elevation and survival of implants inserted in combination with sinus floor elevation. J Clin Periodontol 35(8 Suppl):216–240
Pöhling S, Pippig SD, Hellerbrand K, Siedler M, Schütz A, Dony C (2006) Superior effect of MD05, beta-tricalcium phosphate coated with recombinant human growth/differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model. J Periodontol 77:1582–1590
Polimeni G, Wikesjö UME, Susin C, Qahash M, Shanaman RH, Prasad H, Rohrer MD, Hall J (2010) Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations. J Clin Periodontol 37:759–768
Roldán JC, Jepsen S, Schmidt C, Knüppel H, Rueger DC, Açil Y, Terheyden H (2004) Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Clin Oral Implants Res 15:716–723
Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Özkaynak E, Oppermann H, Rueger D (1992) Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352–20362
Sanz-Sánchez I, Ortiz-Vigón A, Sanz-Martín I, Figuero E, Sanz M (2015) Effectiveness of lateral bone augmentation on the alveolar crest dimension: a systematic review and meta-analysis. J Dent Res 94(9 Suppl):128S–142S
Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM, Wikesjö UME (1996) Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16:525–537
Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UME (1997) Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 8:367–374
Stavropoulos A, Becker J, Capsius B, Açil Y, Wagner W, Terheyden H (2011) Histological evaluation of maxillary sinus floor augmentation with recombinant human growth and differentiation factor-5-coated ß-tricalcium phosphate: results of a multicenter randomized clinical trial. J Clin Periodontol 38:966–974
Summers RB (1994) The osteotome technique: Part 3–Less invasive methods of elevating the sinus floor. Compend Contin Educ Dent 15:698–704
Susin C, Qahash M, Polimeni G, Lu PH, Prasad H, Rohrer MD, Hall J, Wikesjö UME (2010) Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations. J Clin Periodontol 37:574–581
Tan WC, Lang NP, Zwahlen M, Pjetursson BE (2008) A systematic review of the success of sinus floor elevation and survival of implants inserted in combination with sinus floor elevation. Part II: transalveolar technique. J Clin Periodontol 35(8 Suppl):241–254
Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjö UME (2002) Peri-implant bone regeneration using rhBMP-2/ACS in a canine model: a dose-response study. J Periodontal Res 37:93–100
Terheyden H, Jepsen S, Möller B, Tucker MM, Rueger DC (1999) Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. A histometric study in miniature pigs. Clin Oral Implants Res 10:510–521
Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, Boyne PJ (2009) Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67:1947–1960
Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899
Wang EA, Rosen V, D’Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenburg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220–2224
Weng D, Pöhling S, Pippig S, Bell M, Richter EJ, Zuhr O, Hürzeler MB (2009) The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs. Int J Oral Maxillofac Implants 24:31–37
Wikesjö UME, Qahash M, Thomson RC, Cook AD, Rohrer MD, Wozney JM, Hardwick WR (2003) Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 5:112–123
Wikesjö UME, Qahash M, Thomson RC, Cook AD, Rohrer MD, Wozney JM, Hardwick WR (2004) rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 15:194–204
Wikesjö UME, Susin C, Qahash M, Polimeni G, Leknes KN, Shanaman RH, Prasad HS, Rohrer MD, Hall J (2006) The critical-size supraalveolar peri-implant defect model: characteristics and use. J Clin Periodontol 33:846–854
Wikesjö UME, Qahash M, Polimeni G, Susin C, Shanaman RH, Rohrer MD, Wozney JM, Hall J (2008) Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol 35:1001–1010
Wikesjö UME, Qahash M, Huang Y-H, Xiropaidis AV, Polimeni G, Susin C (2009) Bone morphogenetic proteins for periodontal and alveolar indications; biological observations – clinical implications. Orthod Craniofac Res 12:263–270
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Acknowledgments
Earlier versions of this text have been published for reviews in journals and book chapters. The text is continuously subject to revisions and updating as new information becomes available in our laboratory. Studies elaborated herein conducted in our laboratories were supported by W.L. Gore & Associates, Genetics Institute, Wyeth Research, Medtronic, Daewoong Pharmaceuticals, and Nobel Biocare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Wikesjö, U.M.E., Susin, C. (2017). BMPs in Dental Medicine: Promises and Challenges. In: Vukicevic, S., Sampath, K. (eds) Bone Morphogenetic Proteins: Systems Biology Regulators. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-47507-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-47507-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47505-9
Online ISBN: 978-3-319-47507-3
eBook Packages: MedicineMedicine (R0)